| Dr Gregory J Beirne, DO | |
|
3015 N Ballas Rd, Dept Emergency Med, Saint Louis, MO 63131-2329 | |
| (314) 966-5000 | |
| (314) 747-3338 |
| Full Name | Dr Gregory J Beirne |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 3015 N Ballas Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891707097 | NPI | - | NPPES |
| 208835306 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 113573 (Missouri) | Secondary |
| 207P00000X | Emergency Medicine | 113573 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
Just-published research led by a psychologist at the University of Georgia shows that behavioral economic analysis may lead to an improved understanding of craving for alcohol and other drugs. This method of studying how craving alters the way a person values a drug is fairly new, but according to the study, it may well help assess cravings more accurately and contribute to identifying more effective ways to defeat addictions.
Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104866656 PECOS PAC ID: 9830008770 Enrollment ID: O20040205000494 |
News Archive
Just-published research led by a psychologist at the University of Georgia shows that behavioral economic analysis may lead to an improved understanding of craving for alcohol and other drugs. This method of studying how craving alters the way a person values a drug is fairly new, but according to the study, it may well help assess cravings more accurately and contribute to identifying more effective ways to defeat addictions.
Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory J Beirne, DO Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 966-5000 | Dr Gregory J Beirne, DO 3015 N Ballas Rd, Dept Emergency Med, Saint Louis, MO 63131-2329 Ph: (314) 966-5000 |
News Archive
Just-published research led by a psychologist at the University of Georgia shows that behavioral economic analysis may lead to an improved understanding of craving for alcohol and other drugs. This method of studying how craving alters the way a person values a drug is fairly new, but according to the study, it may well help assess cravings more accurately and contribute to identifying more effective ways to defeat addictions.
Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
Sean Oliver Cavanaugh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 S Euclid Ave # 8072, Washington University Emergency Medicine, Saint Louis, MO 63110 Phone: 314-362-9177 | |
John Verhey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-9177 | |
Dr. Mackenzie Ann Mcknight, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-9177 | |
Nagla Abdelmalek, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11133 Dunn Rd, Saint Louis, MO 63136 Phone: 314-653-5663 | |
Dr. Jose I Alvarez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6150 Oakland Ave, Saint Louis, MO 63139 Phone: 314-768-3090 Fax: 314-768-3031 | |
Addie Burtle, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-9177 | |
Dr. Opeolu Makanju Adeoye, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Dept Emergency Med, Saint Louis, MO 63110 Phone: 314-362-9123 Fax: 314-362-0478 |